ATR
Aptargroup·NYSE
--
--(--)
--
--(--)
Signals Analysis
Bullish signal 5
Bearish signal 0
Stock Price Surged Significantly
Dividend Aristocrat
High Cash/net Profit Ratio
Revenue Beats Expectation
EPS Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About ATR
Aptargroup, Inc.
A global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active material science solutions and services
265 Exchange Drive, Suite 301, Crystal Lake, IL 60014
--
Aptargroup, Inc., was incorporated in Delaware in 1992. The company is a global leader in the design and manufacture of dosing, dispensing and protection technologies for pharmaceuticals and consumer products. Aptargroup serves a number of attractive end markets including pharmaceuticals, beauty, food, beverages, personal care and home care. Leveraging market expertise, proprietary design, engineering and science to create innovative solutions for many of the world's leading brands, Aptargroup in turn brings meaningful change to the lives, looks, health and homes of millions of patients and consumers around the world.
Company Financials
EPS
ATR has released its 2025 Q4 earnings. EPS was reported at 1.25, versus the expected 1.23, beating expectations. The chart below visualizes how ATR has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
ATR has released its 2025 Q4 earnings report, with revenue of 962.74M, reflecting a YoY change of 13.52%, and net profit of 74.27M, showing a YoY change of -26.37%. The Sankey diagram below clearly presents ATR's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
You can ask Aime
No Data
